Conference Coverage

Novel Long-Acting Insulin Causes Less Hypoglycemia

Publish date: June 13, 2012

 

FROM THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS

All of the reported studies were funded by Novo Nordisk.

Pages

Recommended Reading

Less Vascular Care Tied to More Amputations
Type 2 Diabetes ICYMI
Early, Aggressive Glucose Control in Prediabetes Key
Type 2 Diabetes ICYMI
Gastric Bypass Induces Diabetes Remission in Mildly Obese
Type 2 Diabetes ICYMI
Systematic QI Strategies Lift all Boats in Diabetes Care
Type 2 Diabetes ICYMI
Exenatide Bests Glimepiride as a Metformin Add-On
Type 2 Diabetes ICYMI
Rapid HbA1c Rise in a Child? Intensify Treatment Fast
Type 2 Diabetes ICYMI
Aggressive BP Lowering in Diabetes No Boost to CVD Outcomes
Type 2 Diabetes ICYMI
SEARCH Turns Up More Diabetes in Youth
Type 2 Diabetes ICYMI
Three Glargine Studies Find No Link to Cancer
Type 2 Diabetes ICYMI
Add-On Glargine Bests Sitagliptin for Regaining Glucose Control
Type 2 Diabetes ICYMI